Financials
Value Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses ———— — Research & development ———— — Operating income -62.89 K-152.6 K-126.64 K-162.38 K -504.5 K Non-Operating Income, Total 01.17 M1.13 M1.04 M 3.33 M Interest expense, net of interest capitalized 100 K100 K100 K100 K 400 K Non-Operating Income, excl. Interest Expenses -100 K1.07 M1.03 M935.98 K 2.93 M Unusual income/expense ———— — Pretax income -62.89 K1.01 M1.01 M873.61 K 2.83 M Equity in earnings ———— — Taxes ———— — Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations -62.89 K1.01 M1.01 M873.61 K 2.83 M Discontinued operations ———— — Net income -62.89 K1.01 M1.01 M873.61 K 2.83 M Dilution adjustment ——1.13 M1.04 M — Preferred dividends ——1.13 M1.04 M — Diluted net income available to common stockholders -62.89 K1.01 M1.01 M873.61 K 2.83 M Basic earnings per share (Basic EPS) -0.030.070.080.06 0.81 Diluted earnings per share (Diluted EPS) -0.030.070.090.06 0.85 Average basic shares outstanding 2.5 M2.74 M2.87 M3.25 M — Diluted shares outstanding 2.5 M3 M3.06 M3.25 M — EBITDA ———— — EBIT ———— — Cost of revenue ———— — Other cost of goods sold ———— — Depreciation & amortization (cash flow) ———— —